Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02901587 · ClinicalTrials.gov registry record · Phase 1

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

A Phase 1 study of Schizophrenia and Schizoaffective Disorder, sponsored by H. Lundbeck A/S.

Completed
Registry status
Phase 1
Development phase
119
Enrollment target
1
Study location

NCT02901587 is a Phase 1 study of Schizophrenia and Schizoaffective Disorder that has completed, run by H. Lundbeck A/S. The registered enrollment target is 119 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02901587, a Phase 1 study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by H. Lundbeck A/S.

COMPLETED
Registry status
Phase 1
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effect of Lu AF35700 on electrical activity in the heart as measured on an electrocardiogram (ECG) in patients with schizophrenia or schizoaffective disorder after 6 weeks of treatment

Conditions Studied

Schizophrenia Schizoaffective Disorder

Interventions

  • DRUG Lu AF35700 (10 mg/day)
  • DRUG Lu AF35700 (30 mg/day)
  • DRUG Quetiapine (Seroquel XR® 800 mg/day)

Study Locations (1)

California

  • US1104 - Long Beach

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2016-09
Est. Completion 2018-04-18
Phase Phase 1

Sponsor

H. Lundbeck A/S

72 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02901587

The ClinicalTrials.gov registry entry for NCT02901587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (46% lower). The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions - of which Lu AF35700 (10 mg/day) is the first listed.

NCT02901587 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02901587 about?

NCT02901587 is a clinical study titled "Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder". The purpose of this study is to investigate the effect of Lu AF35700 on electrical activity in the heart as measured on an electrocardiogram (ECG) in patients with schizophrenia or schizoaffective disorder after 6 weeks of treatment

What is the current status of trial NCT02901587?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 119 participants. The study started on 2016-09. Estimated completion is 2018-04-18.

What conditions does trial NCT02901587 study?

This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.

What interventions are being tested in trial NCT02901587?

The interventions under investigation include: Lu AF35700 (10 mg/day) (DRUG), Lu AF35700 (30 mg/day) (DRUG), Quetiapine (Seroquel XR® 800 mg/day) (DRUG).

Who is sponsoring clinical trial NCT02901587?

This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02901587 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Schizoaffective Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.